Pipeline Vantage with Shield Technology is a new flow diverter with enhanced design features for both the delivery system and implant
India Medtronic, a wholly-owned subsidiary of Medtronic — a global leader in healthcare technology, announced the launch of CE marked fourth-generation flow diverter, Pipeline Vantage with Shield Technology for endovascular treatment of brain aneurysms. Pipeline Vantage with Shield Technology is a new flow diverter with enhanced design features for both the delivery system and implant. These features allow physicians to deliver, deploy and treat brain aneurysms and intracranial aneurysms with greater ease and reliability while providing a scaffold that promotes the growth of cells in the inner lining of the target blood vessel.
“Since 2013, we’ve been disrupting aneurysm treatment, advancing the practice and raising the standard of care in India. Medtronic is consistently committed to bringing innovative technologies to India to improve the quality of life for patients and ease of doing the procedure for surgeons. Our newest Pipeline Vantage Embolization Device comes with a one-of-its-kind warranty for device efficacy. With this, we hope to boost patient assurance on our offerings while encouraging flow diversion as a form of therapy for aneurysms,” said Rahul Arora, Director of Neurosciences Therapies, Medtronic India.
With the commitment to advance access to healthcare in India, Medtronic is also introducing a first-of-its-kind warranty programme called the PED Warranty Program. Through the warranty programme, patients treated with Medtronic’s Pipeline Embolization Device (Pipeline Flex Embolization Device with Shield Technology/ Pipeline Vantage with Shield Technology) will receive warranty coverage.
Flow diversion therapy has lesser chances of re-establishment of blood flow into the occluded aneurysm than other modalities with comparable acute morbidity and mortality rates. The Pipeline embolisation device is the most studied flow diverter worldwide with a proven safety and efficacy profile. Medtronic’s fourth-generation PED Pipeline Vantage Embolization Device with Shield Technology has been designed keeping in mind the strong clinical evidence for flow diverters as a mode of treatment for aneurysms.
